Product Images Methotrexate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Methotrexate NDC 0703-3675 by Teva Parenteral Medicines, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula - image 1

structural formula - image 1

carton 50mg-2mL - image 2

carton 50mg-2mL - image 2

This is a description of Methotrexate Injection, USP, a cytotoxic drug that is used as an isotonic liquid for Intravenous, Intramuscular, Intrathecal, or Subcutaneous administration. It comes in a 2mL single-dose vial, containing 50 mg methotrexate, USP, and is preservative-free and sterile. The drug should be discarded if unused. The inactive ingredients include sodium chloride, may contain hydrochloric acid and/or sodium hydroxide to adjust the pH. The product is manufactured in the Netherlands by Pharmachemie BY and is manufactured for Teva Pharmaceuticals USA, Inc. It also includes a warning to see the package insert for full prescribing information and boxed warnings. It should be stored at 20° to 25° Celsius and protected from light. The text includes a serialized coding area, but does not provide any meaningful information.*

carton 250mg-10mL - image 3

carton 250mg-10mL - image 3

This is a description of a medicine labeled as Methotrexate Injection, USP. It is a 250mg/10mL isotonic liquid cytotoxic agent that can be administered through various means such as intravenous, intramuscular, intrathecal, or subcutaneous injections. The medicine comes in a 10mL single-dose vial and must be discarded after its use. It is manufactured by Pharmacheme BY in Haarlem, The Netherlands, and is distributed in the United States by Teva Pharmaceuticals USA Inc. The active ingredient of Methotrexate Injection, USP is methotrexate, and each vial contains 250mg of it. Some of the inactive ingredients present in the medicine may include sodium chloride, sodium hydroxide, and/or hydrochloric acid.*

carton 1g-40mL - image 4

carton 1g-40mL - image 4

This is a medication called Methotrexate that is available in a 40mL single-dose vial, with 25 mg/mL concentration as an isotonic liquid for intravenous, intramuscular, intrathecal, and subcutaneous administration. The drug is considered a cytotoxic agent and does not contain preservatives. The vial must be discarded after use, and the medication should be kept at a controlled temperature between 20°C to 25°C while protecting it from light. The vial contains 1,000 mg of methotrexate, with inactive sodium chloride (196 mg), and the pH adjusted to 8.5 with sodium hydroxide and/or hydrochloric acid. The manufacturer is Pharmachemie BV in Haarlem, Netherlands, produced for Teva Pharmaceuticals USA in Parsippany, NJ. The packaging insert and warnings should be carefully read before using this medication.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.